Polysomnography Preparation Guidelines
Polysomnography should be performed in conjunction with a comprehensive sleep evaluation that includes assessment of sleep-related symptoms, medical comorbidities, and medication use, with the study conducted under supervision of board-certified sleep medicine providers in accredited sleep centers. 1
Pre-Test Clinical Evaluation Requirements
Before scheduling polysomnography, clinicians must conduct a thorough sleep evaluation to determine:
- Presence of OSA risk factors: Excessive daytime sleepiness, habitual loud snoring, witnessed apneas or gasping/choking, and diagnosed hypertension 1
- Comorbid conditions that mandate in-laboratory PSG rather than home testing:
- Significant cardiorespiratory disease (heart failure, severe COPD)
- Neuromuscular conditions with potential respiratory muscle weakness
- Chronic opioid medication use
- History of stroke
- Severe insomnia
- Suspected central sleep apnea or hypoventilation 1
Patient Selection Algorithm
For uncomplicated patients (absence of above conditions) with suspected moderate-to-severe OSA, either polysomnography or home sleep apnea testing may be appropriate 1. However, polysomnography remains the gold standard diagnostic test and should be the default choice when:
- Non-respiratory sleep disorders are suspected (narcolepsy, parasomnias, periodic limb movements, REM behavior disorder) 1
- Initial home sleep testing is negative, inconclusive, or technically inadequate 1
- High clinical suspicion persists despite negative testing 1
Technical Preparation Standards
The polysomnogram must include monitoring of:
- Neurophysiologic parameters: EEG (minimum 4 channels), electro-oculography, chin and limb electromyography
- Respiratory parameters: Nasal pressure, chest/abdominal respiratory effort (inductance plethysmography), pulse oximetry
- Cardiovascular monitoring: Electrocardiography
- Body position sensor 2, 3
A technically adequate study requires a minimum of 4 hours of scorable data for both oximetry and airflow measurements 1.
Split-Night Protocol Consideration
When clinically appropriate, a split-night protocol (diagnostic study followed by CPAP titration in the same night) may be used rather than full-night diagnostic-only polysomnography, though this carries a WEAK recommendation 1. This approach can reduce costs and expedite treatment initiation but requires adequate diagnostic data in the first portion of the night.
Critical Pitfalls to Avoid
Do not use questionnaires or prediction algorithms alone to diagnose OSA without confirmatory polysomnography or home sleep testing—this carries high risk of missed diagnoses with downstream morbidity and mortality consequences 1
Do not substitute home testing for in-laboratory PSG in complicated patients with cardiopulmonary disease, neuromuscular conditions, or suspected non-OSA sleep disorders—the accuracy is insufficient in these populations 1
Do not accept a single negative test as definitive when clinical suspicion remains high—consider repeat polysomnography 1
Follow-Up Requirements
The guideline emphasizes that diagnostic testing must include adequate follow-up to ensure appropriate interpretation of results and treatment initiation when indicated 1. This is not merely a technical procedure but part of a comprehensive diagnostic and management pathway that directly impacts patient morbidity and mortality through timely OSA diagnosis and treatment.